One way to reconcile these counterintuitive findings is to consider the possibility that Rap1a may have different roles in GBM CSCs versus non-CSCs, as well as unknown effects on tumor progression in vivo versus cell culture. This evidence concerns the gene RAP1A and neoplasm.